Step 1 topics → Biochemistry → Pentose Phosphate Pathway (PPP / HMP Shunt)

Pentose Phosphate Pathway (PPP / HMP Shunt)

USMLE Step 1 trap: Confuses NADPH produced by PPP with NADH produced by glycolysis. The PPP produces NADPH (not NADH), which is used for reductive biosynthesis and the glutathione antioxidant system.

The Pentose Phosphate Pathway (PPP), also called the HMP shunt, is an alternative route for glucose-6-phosphate that runs parallel to glycolysis but serves completely different purposes. It doesn't generate ATP — its entire point is to produce NADPH for reductive reactions and ribose-5-phosphate for nucleotide synthesis. Students consistently confuse G6PD deficiency with chronic granulomatous disease: both involve NADPH, but G6PD deficiency means RBCs can't make NADPH, while CGD means phagocytes can't use it — and mixing these up on USMLE Step 1 is a very common and avoidable error. USMLE Step 1 tests this pathway heavily because it connects directly to both of these clinical entities.

The exam hits this concept from three main angles. First, pure product recognition — knowing what the PPP makes and why those products matter. Second, G6PD deficiency as a pathology — the mechanism, what triggers a crisis, and what you see on the peripheral smear. Third, NADPH's role in the phagocyte respiratory burst, which is where CGD enters the picture. These angles sound distinct but students constantly conflate them, especially the NADPH/NADH mix-up and the CGD/G6PD confusion.

What makes this topic tricky is that NADPH shows up in multiple contexts — glutathione recycling, fatty acid synthesis, and the respiratory burst — and students tend to blur the enzymes that make it versus the enzymes that use it. G6PD makes NADPH; NADPH oxidase uses it. Those are different enzymes, different diseases, different patients. USMLE Step 1 will absolutely write a vignette designed to exploit that confusion, so building a clean mental map here pays off.

From real student decks
92%have cards covering this topic
78%have mature cards
2.0median lapses in 14 days

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: The PPP produces NADH like glycolysis does.
Right: The PPP produces NADPH (not NADH), which is used for reductive biosynthesis and the glutathione antioxidant system.
NADH and NADPH are structurally similar but functionally distinct — glycolysis and the TCA cycle produce NADH, which feeds the electron transport chain to make ATP. The PPP produces NADPH, which is used for reductive biosynthesis (like fatty acid synthesis) and, critically, for regenerating reduced glutathione to neutralize oxidative stress. Confusing the two leads to wrong answers on any question about antioxidant defense or why RBCs without mitochondria are still vulnerable to oxidative damage.
Common mistake
Wrong: G6PD deficiency causes hemolysis spontaneously at baseline.
Right: G6PD deficiency causes hemolytic crises only upon oxidative stress triggers such as primaquine, dapsone, fava beans, or infections.
G6PD-deficient individuals are typically asymptomatic at baseline because their baseline oxidative load is manageable. It's only when an oxidative stressor — primaquine, dapsone, fava beans, or an infection — floods RBCs with reactive oxygen species that glutathione can't keep up, hemoglobin denatures, and hemolysis occurs. Exam vignettes will always include an exposure or stressor; if someone with G6PD deficiency is just 'living their life,' they won't be in hemolytic crisis.
Common mistake
Wrong: CGD is caused by G6PD deficiency because both involve NADPH.
Right: CGD is caused by a defect in NADPH oxidase (not G6PD), preventing the respiratory burst in phagocytes despite normal NADPH production.
Both G6PD deficiency and CGD involve NADPH, but they affect completely different steps. G6PD deficiency means RBCs can't make enough NADPH, so they can't protect themselves from oxidative stress. CGD means phagocytes have normal NADPH production but a broken NADPH oxidase enzyme, so they can't use NADPH to generate the superoxide needed to kill catalase-positive organisms. G6PD deficiency → hemolytic anemia. CGD → recurrent infections with catalase-positive bugs. Don't mix these up.
Common mistake
Wrong: G6PD deficiency produces spherocytes on peripheral smear like hereditary spherocytosis.
Right: G6PD deficiency produces Heinz bodies (denatured hemoglobin) and bite cells on peripheral smear, not spherocytes.
Hereditary spherocytosis and G6PD deficiency both cause hemolytic anemia, but the smear findings are completely different and the exam tests exactly this distinction. In hereditary spherocytosis, spectrin defects cause RBCs to lose membrane and become spheres. In G6PD deficiency, oxidative damage denatures hemoglobin into Heinz bodies (visible with crystal violet stain), and macrophages chew out those clumps leaving 'bite cells' on a routine smear. Seeing spherocytes should direct your thinking to spectrin/ankyrin defects, not G6PD.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the two key products of the PPP — NADPH and ribose-5-phosphate — and be able to explain what each is used for (NADPH: reductive biosynthesis and glutathione recycling; ribose-5-phosphate: nucleotide synthesis).
  2. Understand G6PD deficiency mechanistically: why RBCs are vulnerable, what oxidative triggers precipitate hemolytic crises (primaquine, dapsone, fava beans, infections), and what the peripheral smear shows (Heinz bodies and bite cells, not spherocytes).
  3. Know that NADPH is required for the respiratory burst in phagocytes, and that CGD results from a defect in NADPH oxidase — not from G6PD deficiency — even though both conditions involve NADPH.

Can you avoid these mistakes?

A 22-year-old man with known G6PD deficiency is started on primaquine for malaria prophylaxis. Three days later he develops jaundice and dark urine. His peripheral smear shows bite cells. What enzyme is deficient, what product is therefore low, and what is the downstream consequence that caused the hemolysis?
A child has recurrent pneumonias caused by Staphylococcus aureus and Aspergillus species. Nitroblue tetrazolium (NBT) test is negative. Is this G6PD deficiency or CGD? What enzyme is actually defective, and how does it normally use NADPH?
You're reviewing a question stem: 'A patient has hemolytic anemia with spherocytes on peripheral smear.' Should you be thinking G6PD deficiency or hereditary spherocytosis? What smear findings would make you switch to G6PD deficiency instead?
Name the two major products of the pentose phosphate pathway and give one specific downstream use for each. Then explain why RBCs are particularly dependent on the PPP compared to most other cell types.

Related topics

Glycolysis (Pathway and ATP Yield) Nucleotide and Nucleic Acid Structure DNA Replication DNA Repair Pathways Mutations and Their Consequences

See how your Anki deck covers this topic.

Upload your deck for a free audit →